Subject matter experts to share best practices for utilizing pre-clinical tools to speed progress toward a cure for Parkinson's disease
MANASSAS, Va.
Subject matter experts from ATCC, a global
leader in biological materials development, management and standards, will
partner with The Michael J. Fox Foundation for Parkinson's Research (MJFF) to
facilitate a corporate workshop at the International Society for Biological and
Environmental Repositories (ISBER) 2017 Annual Meeting in Toronto, May 9-12.
ATCC's Liz Kerrigan, director of Commercial
Partnerships and Standards, and Maryellen de Mars, Ph.D., senior director of
Standards Resource Center, will join forces with MJFF Associate Director of
Research Programs Nicole Polinski, Ph.D., to present "MJFF and ATCC
Partnering for Success" on Wednesday, May 10 at 7:45 a.m. The workshop
will focus on best practices for providing high quality biological materials
and services to the global scientific community, and will discuss the MJFF
Pre-clinical Tools Program designed to promote the development and
accessibility of critical research tools for better understanding of
Parkinson's disease pathogenic mechanisms, and new and improved treatments.
Parkinson's is a chronic, degenerative
neurological disorder that affects one in 100 people over age 60. Recent
research indicates that as many as one million Americans, and more than five
million people worldwide, live with Parkinson's disease.
In 2016, ATCC released
three cell lines for
investigating biological processes associated with LRRK2, a key Parkinson's
disease genetic target. The Michael J. Fox Foundation funded the production and
validation of these cell lines. ATCC also continues to work with MJFF to
provide additional research tools, and is currently working on the production,
validation, storage and future distribution of Parkin-expressing HeLa cells,
which will be available later in 2017.
"Research tools and reference reagents
enable scientists to gain insight into the mechanisms of disease, and are
critical in the development of new treatments," said Dr. Raymond Cypess,
ATCC's Chairman and CEO. "These tools and reagents are also critical in
recruiting scientists to work in specific disease areas. As partners to the
scientific community for more than 90 years, ATCC is proud to join MJFF at
ISBER to discuss the significance of these tools and the need to increase
access and availability for the global research community."
"The Michael J. Fox Foundation's
collaboration with ATCC delivers vital pre-clinical tools to the Parkinson's
research community to address field-wide challenges and advance disease understanding,"
said Nicole Polinski, Ph.D., associate director of research programs at MJFF.
"We are pleased to join ATCC at ISBER to highlight the importance of these
tools in developing therapeutic strategies and speeding PD research."
About ATCC
ATCC
is a leader in biological materials management supporting the scientific
community and government with research and development, products, and services
in support of global health issues. With a history of innovation spanning more
than 90 years, ATCC offers the world's largest and most diverse collection of
human and animal cell lines, microorganisms, biological products, and
standards. ATCC is a non-profit organization with headquarters in Manassas, Va.
For more information about ATCC, visit us at www.atcc.org.
SOURCE American Type
Culture Collection
http://www.prnewswire.com/news-releases/atcc-and-the-michael-j-fox-foundation-for-parkinsons-research-to-facilitate-workshop-at-isber-annual-meeting-300453151.html
No comments:
Post a Comment